Es gab 50 kürzliche Insider-Transaktionen für Virios Therapeutics, Inc. (VIRI), darunter 48 Käufe und 2 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.42M und die gesamten Insider-Verkäufe auf $466.38.
Bedeutende Insider mit kürzlicher Aktivität umfassen Thomas John C, Whitley Richard James, De La Rosa Abel. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — VIRI
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-02-26 |
Thomas John C |
Director |
RSU-Zuteilung |
4,167 |
$0.36 |
$1.49K |
4,167 |
| 2024-02-26 |
Whitley Richard James |
Director |
RSU-Zuteilung |
4,000 |
$0.36 |
$1.43K |
4,000 |
| 2024-02-26 |
De La Rosa Abel |
Director |
RSU-Zuteilung |
3,959 |
$0.36 |
$1.41K |
3,959 |
| 2024-02-26 |
Keefer David R |
Director |
RSU-Zuteilung |
4,709 |
$0.36 |
$1.68K |
4,709 |
| 2024-02-26 |
Walsh Angela |
SVP of Finance |
RSU-Zuteilung |
63,618 |
$0.36 |
$22.71K |
63,618 |
| 2024-02-26 |
Grosswald Ralph |
SVP of Operations |
RSU-Zuteilung |
62,568 |
$0.36 |
$22.34K |
62,568 |
| 2024-02-26 |
Pridgen William |
Director |
RSU-Zuteilung |
2,917 |
$0.36 |
$1.04K |
2,917 |
| 2024-02-26 |
Gendreau Roger Michael |
Chief Medical Officer |
RSU-Zuteilung |
88,085 |
$0.36 |
$31.45K |
88,085 |
| 2024-02-26 |
Duncan Gregory Scott |
Chief Executive Officer |
RSU-Zuteilung |
138,835 |
$0.36 |
$49.56K |
138,835 |
| 2024-02-26 |
Burch Richard Alan |
Director |
RSU-Zuteilung |
2,917 |
$0.36 |
$1.04K |
2,917 |
| 2023-08-21 |
Pridgen William |
Director |
Informierter Kauf |
15,335 |
$1.30 |
$19.99K |
52,045 |
| 2023-08-17 |
Duncan Gregory Scott |
Chief Executive Officer |
Informierter Kauf |
25,000 |
$1.25 |
$31.25K |
57,461 |
| 2023-06-15 |
Thomas John C |
Director |
RSU-Zuteilung |
5,250 |
$1.85 |
$9.71K |
5,250 |
| 2023-06-15 |
Whitley Richard James |
Director |
RSU-Zuteilung |
5,250 |
$1.85 |
$9.71K |
5,250 |
| 2023-06-15 |
De La Rosa Abel |
Director |
RSU-Zuteilung |
5,250 |
$1.85 |
$9.71K |
5,250 |
| 2023-06-15 |
Keefer David R |
Director |
RSU-Zuteilung |
5,250 |
$1.85 |
$9.71K |
5,250 |
| 2023-06-15 |
Pridgen William |
Director |
RSU-Zuteilung |
5,250 |
$1.85 |
$9.71K |
5,250 |
| 2023-06-15 |
Burch Richard Alan |
Director |
RSU-Zuteilung |
5,250 |
$1.85 |
$9.71K |
5,250 |
| 2022-12-12 |
Duncan Gregory Scott |
Chief Executive Officer |
RSU-Zuteilung |
410,000 |
$0.28 |
$114.35K |
410,000 |
| 2022-12-12 |
Walsh Angela |
SVP of Finance |
RSU-Zuteilung |
80,000 |
- |
- |
80,000 |
| 2022-12-12 |
Grosswald Ralph |
SVP of Operations |
RSU-Zuteilung |
80,000 |
- |
- |
80,000 |
| 2022-12-12 |
Gendreau Roger Michael |
Chief Medical Officer |
RSU-Zuteilung |
80,000 |
- |
- |
80,000 |
| 2022-12-12 |
Duncan Gregory Scott |
Chief Executive Officer |
RSU-Zuteilung |
480,000 |
- |
- |
480,000 |
| 2022-12-08 |
Whitley Richard James |
Director |
Informierter Verkauf |
1,800 |
$0.26 |
$466.38 |
700 |
| 2022-06-23 |
Thomas John C |
Director |
RSU-Zuteilung |
5,250 |
- |
- |
5,250 |
| 2022-06-23 |
Whitley Richard James |
Director |
RSU-Zuteilung |
5,250 |
$4.23 |
$22.21K |
5,250 |
| 2022-06-23 |
De La Rosa Abel |
Director |
RSU-Zuteilung |
5,250 |
- |
- |
5,250 |
| 2022-06-23 |
Keefer David R |
Director |
RSU-Zuteilung |
5,250 |
$4.23 |
$22.21K |
5,250 |
| 2022-06-23 |
Walsh Angela |
SVP of Finance |
RSU-Zuteilung |
40,000 |
$4.23 |
$169.2K |
40,000 |
| 2022-06-23 |
Grosswald Ralph |
SVP of Operations |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2022-06-23 |
Pridgen William |
Director |
RSU-Zuteilung |
5,250 |
$4.23 |
$22.21K |
5,250 |
| 2022-06-23 |
Gendreau Roger Michael |
Chief Medical Officer |
RSU-Zuteilung |
40,000 |
$4.23 |
$169.2K |
40,000 |
| 2022-06-23 |
Duncan Gregory Scott |
Chief Executive Officer |
RSU-Zuteilung |
90,000 |
$4.23 |
$380.7K |
90,000 |
| 2022-06-23 |
Burch Richard Alan |
Director |
RSU-Zuteilung |
5,250 |
- |
- |
5,250 |
| 2022-05-23 |
Walsh Angela |
SVP of Finance |
Informierter Kauf |
2,000 |
$4.58 |
$9.15K |
3,000 |
| 2022-05-23 |
Duncan Gregory Scott |
Chief Executive Officer |
Informierter Kauf |
7,500 |
$4.52 |
$33.9K |
32,461 |
| 2022-05-18 |
Whitley Richard James |
Director |
Informierter Kauf |
500 |
$4.53 |
$2.26K |
2,500 |
| 2022-05-18 |
Pridgen William |
Director |
Informierter Kauf |
241 |
$4.50 |
$1.08K |
36,710 |
| 2022-05-17 |
Pridgen William |
Director |
Informierter Kauf |
13,450 |
$4.38 |
$58.91K |
36,469 |
| 2022-03-29 |
Pridgen William |
Director |
Informierter Kauf |
600 |
$4.94 |
$2.96K |
23,019 |
| 2022-03-23 |
Pridgen William |
Director |
Informierter Kauf |
2,197 |
$5.46 |
$12K |
22,419 |
| 2022-01-27 |
Pridgen William |
Director |
Informierter Kauf |
4,180 |
$5.98 |
$25K |
18,722 |
| 2022-01-07 |
De La Rosa Abel |
Director |
Informierter Kauf |
4,000 |
$5.90 |
$23.58K |
4,000 |
| 2022-01-06 |
Whitley Richard James |
Director |
Informierter Kauf |
1,800 |
$5.72 |
$10.3K |
2,000 |
| 2022-01-04 |
Thomas John C |
Director |
Informierter Kauf |
1,000 |
$5.65 |
$5.65K |
1,000 |
| 2022-01-04 |
Keefer David R |
Director |
Informierter Kauf |
5,000 |
$5.80 |
$28.98K |
5,000 |
| 2022-01-03 |
Pridgen William |
Director |
Informierter Kauf |
2,215 |
$5.43 |
$12.03K |
14,542 |
| 2021-12-31 |
Burch Richard Alan |
Director |
Veräußerung |
- |
- |
- |
147,681 |
| 2021-12-23 |
Whitley Richard James |
Director |
Informierter Kauf |
200 |
$5.73 |
$1.15K |
200 |
| 2021-12-21 |
Pridgen William |
Director |
Informierter Kauf |
8,827 |
$5.66 |
$50K |
12,327 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall